Berlin-based HealthTech company Mika selected by White House Backed CancerX Accelerator Program
The app-based platform Mika, a provider of digital therapeutics (DTx) for all types of cancer, was selected as one of 16 members for the inaugural cohort of the 2024 CancerX Accelerator program supported by the White House.
Mika was chosen from more…